FDAClass IIOctober 23, 2019

Pioglitazone Hydrochloride Tablets USP 15 mg recall: Superpotent

Pioglitazone Hydrochloride Tablets USP 15 mg, 30 count bottles, Rx only, Manufactured for: Macleods Pharma USA, Inc., Plainsboro, NJ, Manufactured by…

Why was Pioglitazone Hydrochloride Tablets USP 15 mg recalled?

Superpotent

What should I do if I have this product?

Review the official FDA enforcement record for current instructions.

What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.

Is my product affected?

Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.

Which lot codes, UPCs or models are affected?

Lot # BPF901A, exp. date 12/2021

Product
Pioglitazone Hydrochloride Tablets USP 15 mg, 30 count bottles, Rx only, Manufactured for: Macleods Pharma USA, Inc., Plainsboro, NJ, Manufactured by…
Recalling firm
Macleods Pharma Usa Inc
Quantity
31,968 bottles
Distribution
Product was shipped to 8 distributors who may have further distributed the product.
Recall date
October 23, 2019
Classification
Class II
Status
Terminated
Agency
FDA (drug)
Open FDA enforcement record Latest recalls